1. Home
  2. RBB vs FBRX Comparison

RBB vs FBRX Comparison

Compare RBB & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RBB Bancorp

RBB

RBB Bancorp

HOLD

Current Price

$20.99

Market Cap

379.0M

Sector

Finance

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$27.46

Market Cap

379.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBB
FBRX
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
379.0M
379.3M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
RBB
FBRX
Price
$20.99
$27.46
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$22.00
$67.00
AVG Volume (30 Days)
69.1K
171.3K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
3.06%
N/A
EPS Growth
24.49
N/A
EPS
1.83
N/A
Revenue
$5,167,000.00
$36,000.00
Revenue This Year
$15.23
N/A
Revenue Next Year
$6.90
N/A
P/E Ratio
$11.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.40
$4.91
52 Week High
$22.69
$35.62

Technical Indicators

Market Signals
Indicator
RBB
FBRX
Relative Strength Index (RSI) 42.54 43.80
Support Level $20.04 $26.67
Resistance Level $22.57 $32.40
Average True Range (ATR) 0.70 2.41
MACD -0.12 -0.35
Stochastic Oscillator 34.67 22.67

Price Performance

Historical Comparison
RBB
FBRX

About RBB RBB Bancorp

RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Share on Social Networks: